Staphylococcal inferantigen (TSST-1) mutant analysis reveals that T cell activation is required for biological effects in the rabbit including the cytokine storm

Toxins

Volumn 2, Issue 9, 2010, Pages 2272-2288

  Stich, Norbert ^a   Waclavicek, Martina ^a   Model, Nina ^a   Eibl, Martha M ^a,b  

^a Biomedizinische Forschungsgesellschaft mbH   (Austria)

^b Immunology Outpatient Clinic   (Austria)

Author keywords

Endotoxin; Inferantigens; Inflammation; Sepsis; T cell involvement

Indexed keywords

INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TOXIC SHOCK SYNDROME TOXIN 1; BACTERIAL TOXIN; CYTOKINE; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL; MUTANT PROTEIN;

ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; RABBIT; STAPHYLOCOCCUS; T LYMPHOCYTE ACTIVATION; TOXIN ANALYSIS; WILD TYPE; ANIMAL; BINDING SITE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECT; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MUTATION; PROTEIN BINDING; T LYMPHOCYTE;

ORYCTOLAGUS CUNICULUS;

ANIMALS; BACTERIAL TOXINS; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROTOXINS; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; LYMPHOCYTE ACTIVATION; MUTANT PROTEINS; MUTATION; PROTEIN BINDING; RABBITS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 79952080230     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins2092272     Document Type: Article

References (29)

1. Dinges, M.M.; Orwin, P.M.; Schlievert, P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 2000, 13, 16-34.
2. Marrack, P.; Blackman, M.; Kushnir, E.; Kappler, J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 1990, 171, 455-464.
3. Faulkner, L.; Cooper, A.; Fantino, C.; Altman, D.M.; Sriskandan, S. The mechanism of inferantigen-mediated toxic shock: not a simple Th1 cytokine storm. J. Immunol. 2005, 175, 6870-6877.
4. Sriskandan, S.; Faulkner, L.; Hopkins, P. Streptococcus pyogenes: Insight into the function of the streptococcal inferantigens. Int. J. Biochem. Cell Biol. 2007, 39, 12-19.
5. Sriskandan, S.; Unnikrishnan, M.; Krausz, T.; Dewchand, H.; van Norden, S.; Cohen, J.; Altmann, D.M. Enhanced susceptibility to inferantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. J. Infect. Dis. 2001, 184, 166-173.
6. Welcher, B.C.; Carra, J.H.; DaSilva, L.; Hanson, J.; David, C.S.; Aman, M.J.; Bavari, S. Lethalshock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: Implications for development of vaccines and therapeutics. J. Infect. Dis. 2002, 186, 501-510.
7. Bonventre, P.F.; Heeg, H.; Edwards, C.K.; Cullen, C.M. A mutation at histidine residue 135 of TSST-1 yields an immunogenic protein with minimal toxicity. Infect. Immun. 1995, 63, 509-515.
8. Kum, W.W.; Wood, J.A.; Chow, A.W. A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defindes a functional site critical for major histocompatibility complex class II binding and inferantigenic activity. J. Infect. Dis. 1996, 174, 1261-1270.
9. Kum, W.S.; Cameron, S.B.; Hung, R.W.Y.; Kalyan, S.; Chow, A.W. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin1 in human peripheral bloodmononuclear cells. Infect. Immun.2001,69, 7544-7549.
10. Dong-Liang, H.; Omoe, K.; Sasaki, S.; Sashinami, H.; Sakuraba, H.; Yokomizo, Y.; Shinagawa, K.; Nakane, A. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J. Infect. Dis. 2003, 188, 743-752.
11. Llewelyn, M.; Sriskandan, S.; Peakman, M.; Ambrozak, D.R.; Douek, D.C.; Kwok, W.W.; Cohen, J.; Altmann, D.M. HLA Class II polymorphisms determine responses to bacterial inferantigens. J. Immunol. 2004, 172, 1719-1726.
12. Roggiani, M.; Stoehr, B.; Leonard, A.; Schlievert, P.M. Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants. Infect. Immun. 1997, 65, 2868-2875.
13. Dinges, M.M.; Gregerson, D.S.; Tripp, T.J.; McCormick, J.K.; Schlievert, P.M. Effects of total body irradiation and cyclosporin A on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome. J. Infect. Dis. 2003, 188, 1142-1145.
14. Schlievert, P.M. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect. Immun. 1982, 36, 123-128.
15. Rossi, R.J.; Muralimohan, G.; Maxwell, J.R.; Vella, A.T. Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation. Int. Immunol. 2004, 16, 1751-1760.
16. Beno, D.W.; Uhing, M.R.; Goto, M.; Chen, Y.; Jiyamapa-Serna, V.A.; Kimura, R.E. Chronic staphylococcal enterotoxin B and LPS induce a bimodal pattern of hepatic dysfunction and injury. Crit. Care Med. 2003, 31, 1154-1159.
17. Waclavicek, M.; Stich, N.; Rappan, I.; Bergmeister, H.; Eibl, M.M. Analysis of the early response to TSST-1 reveals Vβ-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1. J. Leukoc. Biol. 2009, 85, 44-54.
18. Vincent, J.L.; Sakr, Y.; Sprung, C.L.; Ranieri, V.M.; Reinhart, K.; Gerlach, H.; Moreno, R.; Carlet, J.; Le Gall, J.R.; Payen, D. Sepsis in European intensive care units: Results of the SOAP study. Crit. Care Med. 2006, 34, 344-353.
19. Blackwell, C.C.; Mackenzie, D.A.C.; James, V.S.; Elton, R.A.; Zorgani, A.A.; Weir, D.M.; Busuttil, A. Toxigenic bacteria and sudden infant death syndrome (SIDS): Nasopharyngeal flora during the first year of life. FEMS Immunol. Med. Microbiol. 1999, 25, 51-58.
20. Oppenheim, B.A.; Barclay, G.R.; Morris, J.; Knox, F.; Barson, A.; Drucker, D.B.; Crawley, B.A.; Morris, J.A. Antibodies to endotoxin core in sudden infant death syndrome. Arch. Dis. Child. 1994, 70, 95-98.
21. Schlievert, P.M. Alteration of immune function by staphylococcal pyrogenic exotoxin type C: Possible role in toxic-shock syndrome. J. Infect. Dis. 1983, 147, 391-398.
22. Dinges, M.M.; Schlievert, P.M. Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal inferantigen toxic shock syndrome toxin 1. Infect. Immun. 2001, 69, 7169-7172.
23. Parsonnet, J.; Gillis, Z.A.; Richter, A.G.; Pier, G.B. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect. Immun. 1987, 55, 1070-1076.
24. Huston, J.M.; Ochani, M.; Rosas-Ballina, M.; Liao, H.; Ochani, K.; Pavlov, V.A. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxaemia and polymicrobial sepsis. J. Exp. Med. 2006, 203, 1623-1628.
25. + T cells by Staphylococcal enterotoxin B. J. Exp. Med. 1990, 172, 1091-1100.
26. Hopkins, P.A.; Fraser, J.D.; Pridmore, A.C.; Russell, H.H.; Read, R.C.; Sriskandan, S. Inferantigen recognition by HLA class II on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin. Blood 2005, 105, 3655-3662.
27. Blank, C.; Luz, A.; Bendigs, S.; Erdmann, A.; Wagner, H.; Heeg, K. Inferantigen and endotoxin synergize in the induction of lethal shock. Eur. J. Immunol. 1997, 27, 825-833.
28. Beno, D.W.; Uhing, M.R.; Goto, M.; Chen, Y.; Jiyamapa-Serna, V.A; Kimura, R.E. Chronic Staphylococcal enterotoxin B and lipopolysaccharide induce a bimodal pattern of hepatic dysfunction and injury. Crit. Care Med. 2003, 31, 1285-1286.
29. Gampfer, J.; Thon, V.; Gulle, H.; Wolf, H.M.; Eibl, M.M.Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome. Vaccine 2002, 20, 1354-1364.